XML 14 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Payments (Tables)
 3 Months Ended
Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based compensation expense included in consolidated statements of income
The following table summarizes share-based compensation expense included within our condensed consolidated statements of income:
 
For the Three Months
Ended March 31,
(In millions)
2014
 
2013
Research and development
$
29.4

 
$
25.2

Selling, general and administrative
47.2

 
34.3

Subtotal
76.6

 
59.5

Capitalized share-based compensation costs
(2.6
)
 
(2.3
)
Share-based compensation expense included in total cost and expenses
74.0

 
57.2

Income tax effect
(22.3
)
 
(16.6
)
Share-based compensation expense included in net income attributable to Biogen Idec Inc.
$
51.7

 
$
40.6
Summary of share-based compensation expense associated with each of our share-based compensating programs
The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
 
For the Three Months
Ended March 31,
(In millions)
2014
 
2013
Stock options
$
—

 
$
0.3

Market stock units
14.9

 
8.5

Time-vested restricted stock units
29.2

 
27.1

Cash settled performance units
21.4

 
20.4

Performance units
6.3

 
—

Employee stock purchase plan
4.8

 
3.2

Subtotal
76.6

 
59.5

Capitalized share-based compensation costs
(2.6
)
 
(2.3
)
Share-based compensation expense included in total cost and expenses
$
74.0

 
$
57.2
Summary of equity grants to employees, officers and directors under our current stock plans
The following table summarizes our equity grants to employees, officers and directors under our current stock plans:
 
For the Three Months
Ended March 31,
 
2014
 
2013
Market stock units
214,000

 
253,000

Cash settled performance shares
172,000

 
270,000

Performance units
50,000

 
—

Time-vested restricted stock units
392,000

 
638,000